Ayla Yildirim

Ayla Yildirim

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2023 in TrAC Trends in Analytical Chemistry
Verified
Journal Article
Closed access
EEEce Eksin
Ece Eksin
AYAyla Yildirim
Ayla Yildirim
ABAysen Bozoglu
Aysen Bozoglu
Erhan ZorErhan Zor
Erhan Zor
AEArzum Erdem
Arzum Erdem

22 May 2024 in Journal of Electroanalytical Chemistry
Verified
Journal Article
Closed access
AYAyla Yildirim
Ayla Yildirim
MMMELTEM MARAL
MELTEM MARAL
BZBuse Tugba Zaman
Buse Tugba Zaman
ABAysen Bozoglu
Aysen Bozoglu
CDCansu Demir
Cansu Demir
AEArzum Erdem
Arzum Erdem

31 October 2023 in TURKISH JOURNAL OF CHEMISTRY
Verified
Journal Article
Open access
PDF file
AEArzum Erdem
Arzum Erdem
HSHuseyin Senturk
Huseyin Senturk
AYA Yildiz
A Yildiz
MMMELTEM MARAL
MELTEM MARAL
AYAyla Yildirim
Ayla Yildirim
NANesli̇hAn Ceren Ay
Nesli̇hAn Ceren Ay
The interaction of drugs with DNA is important for the discovery of novel drug molecules and for understanding the therapeutic effects of drugs as well as the monitoring of side effects. For this reason, many studies have been carried out to investigate the interactions of drugs with nucleic acids. In recent years, a large number of studies have been performed to electrochemically detect drug-DNA interactions. The fast, sensitive, and accurate results of electrochemical techniques have resulted in a leading role for their implementation in this field. By means of electrochemical techniques, it is possible not only to demonstrate drug-DNA interactions but also to quantitatively analyze drugs. In this context, electrochemical biosensors for drug-DNA interactions have been examined under different headings including anticancer, antiviral, antibiotic, and central nervous system drugs as well as DNA-targeted drugs. An overview of the studies related to electrochemical DNA biosensors developed for the detection of drug-DNA interactions that were reported in the last two decades in the literature is presented herein along with their applications and they are discussed together with their future perspectives.

2 September 2025 in Sensors
Verified
Journal Article
Open access
PDF file
AYAyla Yildirim
Ayla Yildirim
MMMELTEM MARAL
MELTEM MARAL
HSHuseyin Senturk
Huseyin Senturk
AEArzum Erdem
Arzum Erdem
Lignin, the second most abundant biopolymer in nature after cellulose, has attracted attention for its compatibility with carbon-based materials. In this study, lignin-modified single-use pencil graphite electrodes (PGE/LG) were developed for the electrochemical detection of fish sperm DNA (fsDNA), the anticancer drug Mitomycin C (MC), and their interaction. The modified electrodes were characterized using field emission scanning electron microscopy (FE-SEM), energy-dispersive X-ray spectroscopy (EDX), cyclic voltammetry (CV), and electrochemical impedance spectroscopy (EIS) techniques. Differential pulse voltammetry (DPV) in ferri/ferrocyanide redox probe solution was employed for signal monitoring. The detection limits were calculated as 2.95 ng/mL for fsDNA between 101 and 105 ng/mL and 0.22 pg/mL for MC between 1 and 106 pg/mL. Furthermore, the interaction of DNA with MC was evaluated by DPV and EIS techniques. The cross-linking between MC and the guanine bases of DNA inhibited electron transfer, resulting in a decrease in current response and an increase in charge transfer resistance. These results demonstrate the potential of the PGE/LG platform as a cost-effective, sensitive, and rapid biosensor for DNA detection, anticancer drug analysis, and drug–DNA interaction studies.